Stocks and Investing Stocks and Investing
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020
Fri, November 27, 2020
Wed, November 25, 2020
Tue, November 24, 2020
Mon, November 23, 2020

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $33 on, Nov 23rd, 2020


Published on 2024-10-27 14:50:53 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $28 to $33 on, Nov 23rd, 2020.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020